ANAPC7 promotes triple-negative breast cancer progression through ANAPC2-dependent degradation of PCGF2 and activation of STAT3
- DOI
- 10.1158/1541-7786.mcr-26-0497
- Published
- 2026-09-22
- Container
- Molecular Cancer Research
- Publisher
- American Association for Cancer Research (AACR)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1158/1541-7786.mcr-26-0497,
title = {ANAPC7 promotes triple-negative breast cancer progression through ANAPC2-dependent degradation of PCGF2 and activation of STAT3},
author = {Xiaoran Wang and Ran Hao and Mingxin Diao and Dong Ma and Hongyu Zhang and Yingzhan Wang and Jie Hu and Yixin Qi},
year = {2026},
journal = {Molecular Cancer Research},
doi = {10.1158/1541-7786.mcr-26-0497},
url = {https://doi.org/10.1158/1541-7786.mcr-26-0497}
}RIS
TY - JOUR TI - ANAPC7 promotes triple-negative breast cancer progression through ANAPC2-dependent degradation of PCGF2 and activation of STAT3 AU - Xiaoran Wang AU - Ran Hao AU - Mingxin Diao AU - Dong Ma AU - Hongyu Zhang AU - Yingzhan Wang AU - Jie Hu AU - Yixin Qi PY - 2026 JO - Molecular Cancer Research DO - 10.1158/1541-7786.mcr-26-0497 UR - https://doi.org/10.1158/1541-7786.mcr-26-0497 ER -
APA
Wang, X., Hao, R., Diao, M., Ma, D., Zhang, H., Wang, Y., Hu, J., & Qi, Y. (2026). ANAPC7 promotes triple-negative breast cancer progression through ANAPC2-dependent degradation of PCGF2 and activation of STAT3. Molecular Cancer Research. https://doi.org/10.1158/1541-7786.mcr-26-0497
Source records
- crossref · retrieved 2026-09-26T08:01:38.020Z